Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $524.21 | 7 | 63.2% |
| Consulting Fee | $304.70 | 1 | 36.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| bioMerieux Inc | $304.70 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $243.00 | 2 | $0 (2023) |
| ALK-Abello, Inc | $114.95 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $84.11 | 1 | $0 (2023) |
| ABIOMED | $41.82 | 1 | $0 (2024) |
| DePuy Synthes Sales Inc. | $23.12 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $17.21 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64.94 | 2 | ABIOMED ($41.82) |
| 2023 | $327.11 | 3 | AstraZeneca Pharmaceuticals LP ($243.00) |
| 2022 | $436.86 | 3 | bioMerieux Inc ($304.70) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | DePuy Synthes Sales Inc. | MATRIXRIB (Device) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: CMF-Trauma | ||||||
| 08/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $41.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $84.11 | General |
| Category: GENETIC DISEASE | ||||||
| 04/28/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $118.00 | General |
| Category: Respiratory | ||||||
| 04/24/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 12/09/2022 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $114.95 | General |
| Category: Allergy and Immunology | ||||||
| 10/13/2022 | bioMerieux Inc | — | Consulting Fee | Cash or cash equivalent | $304.70 | General |
| 07/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 521 | 993 | $608,726 | $75,136 |
| 2022 | 5 | 504 | 975 | $615,372 | $68,722 |
| 2021 | 4 | 408 | 750 | $323,292 | $53,867 |
| 2020 | 4 | 252 | 394 | $64,774 | $29,900 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 185 | 375 | $269,250 | $34,132 | 12.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 167 | 433 | $216,500 | $26,560 | 12.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 147 | 148 | $109,076 | $12,722 | 11.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 23 | $6,256 | $892.40 | 14.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 11 | 14 | $7,644 | $828.94 | 10.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 196 | 430 | $309,248 | $34,508 | 11.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 146 | 380 | $190,362 | $21,466 | 11.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 135 | 136 | $100,499 | $11,016 | 11.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 14 | 16 | $8,736 | $992.23 | 11.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 13 | $6,526 | $740.46 | 11.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 139 | 284 | $144,824 | $22,648 | 15.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 120 | 317 | $111,443 | $17,649 | 15.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 133 | 133 | $58,170 | $11,037 | 19.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $8,856 | $2,534 | 28.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 81 | 134 | $24,120 | $11,259 | 46.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 84 | 173 | $21,798 | $9,956 | 45.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 70 | 70 | $12,923 | $6,032 | 46.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 17 | $5,933 | $2,653 | 44.7% |
About Dr. Charles Ma, M.D
Dr. Charles Ma, M.D is a Hospitalist healthcare provider based in Kirkland, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2017. The National Provider Identifier (NPI) number assigned to this provider is 1205377579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Ma, M.D has received a total of $828.91 in payments from pharmaceutical and medical device companies, with $64.94 received in 2024. These payments were reported across 8 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($524.21).
As a Medicare-enrolled provider, Ma has provided services to 1,685 Medicare beneficiaries, totaling 3,112 services with total Medicare billing of $227,625. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Location Kirkland, WA
- Active Since 03/20/2017
- Last Updated 12/17/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1205377579
Products in Payments
- TEZSPIRE (Biological) $125.00
- FASENRA (Biological) $118.00
- Odactra (Drug) $114.95
- TAKHZYRO (Biological) $84.11
- Impella (Device) $41.82
- MATRIXRIB (Device) $23.12
- XARELTO (Drug) $17.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Kirkland
Ziad Alsoufi, Md, MD
Hospitalist — Payments: $3,363
Miss. Margaret Kim, M.d, M.D
Hospitalist — Payments: $1,829
Kelly Fujikawa
Hospitalist — Payments: $198.71
Mary Lacy, M.d, M.D
Hospitalist — Payments: $11.92
Dr. Nancy Marshall, Md, MD
Hospitalist
Dr. Tristan Osborn, Md, MD
Hospitalist